Clinical characteristics of a COVID-19 cohort treated at UCLA Ronald Reagan Medical Center during the breaking phase of the pandemic: A retrospective study
Age, Anti-virals, Antibiotics, Body mass index, BMI, COVID‐19, California, Census, Coagulation, Demography, Ethnicities, Gender, Immunosuppressants, Inflammation, Intensive care/intensive care unit, Los Angeles, Obesity, Pandemic, Public health, Ronald Reagan Medical Center, SARS-COV-2, Smoking, Steroids, University of California Los Angeles, UCLA,
Related Posts
Zhang Q, Hutchison ER, Pan C, Warren MF, Keller MP, Attie AD, Lusis AJ, Rey FE. Systems genetics uncovers associations among host amylase locus, gut[...]
Maqsood MH, Zhang RS, Rosenfeld K, Moriarty JM, Rosovsky RP, Horowitz JM, Alviar CL, Bangalore S. Do Pulmonary Embolism Response Teams in Acute Pulmonary Embolism[...]
Ghantous E. Rethinking early anticoagulation in bioprosthetic valve surgery. Int J Cardiol. 2025 Apr 18:133289. doi: 10.1016/j.ijcard.2025.133289. Epub ahead of print. PMID: 40254144.